BioCentury
ARTICLE | Financial News

Obalon Therapeutics amends IPO

October 3, 2016 7:00 AM UTC

Obalon Therapeutics Inc., Carlsbad, Calif. Business: Endocrine/Metabolic Date announced: 2016-09-26 Type: IPO To be raised: Up to $80 million Shares: 5 million Price: $14-$16 Underwriters: UBS; Canacc...